Literature DB >> 9722914

HLA-peptide tetrameric complexes.

G S Ogg1, A J McMichael.   

Abstract

HLA-peptide tetrameric complexes allow the direct ex vivo visualisation of antigen-specific CD8+ T cells and natural killer cells by flow cytometry. Quantitation, phenotypic analysis and isolation of tetramer-binding cells has considerably extended our understanding of cytotoxic T lymphocyte and natural killer cell function.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9722914     DOI： 10.1016/s0952-7915(98)80110-6

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  23 in total

Review 1.  Antigen-recognition properties of murine gamma delta T cells.

Authors:  Y H Chien; J Hampl
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Quantification of antigen-reactive T cells by a modified ELISPOT assay based on freshly isolated blood dendritic cells.

Authors:  M Schmitz; J Rohayem; R Paul; B Weigle; A Stein; E P Rieber
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

3.  A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.

Authors:  K S Froebel; G M Raab; C D'Alessandro; M P Armitage; K M MacKenzie; M Struthers; J M Whitelaw; S Yang
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

4.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.

Authors:  C Yee; J A Thompson; D Byrd; S R Riddell; P Roche; E Celis; P D Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

5.  Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.

Authors:  Nina D Russell; Barney S Graham; Michael C Keefer; M Juliana McElrath; Steve G Self; Kent J Weinhold; David C Montefiori; Guido Ferrari; Helen Horton; Georgia D Tomaras; Sanjay Gurunathan; Lynn Baglyos; Sharon E Frey; Mark J Mulligan; Clayton D Harro; Susan P Buchbinder; Lindsey R Baden; William A Blattner; Beryl A Koblin; Lawrence Corey
Journal:  J Acquir Immune Defic Syndr       Date:  2007-02-01       Impact factor: 3.731

6.  Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques.

Authors:  Shelby L O'Connor; Alex J Blasky; Chad J Pendley; Ericka A Becker; Roger W Wiseman; Julie A Karl; Austin L Hughes; David H O'Connor
Journal:  Immunogenetics       Date:  2007-03-24       Impact factor: 2.846

7.  Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes.

Authors:  Nina Babel; Gordon Brestrich; Lukasz P Gondek; Arne Sattler; Marcin W Wlodarski; Nina Poliak; Nicole Bethke; Andreas Thiel; Markus H Hammer; Petra Reinke; Jaroslaw P Maciejewski
Journal:  J Am Soc Nephrol       Date:  2008-09-17       Impact factor: 10.121

8.  Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography.

Authors:  A Karadimitris; S Gadola; M Altamirano; D Brown; A Woolfson; P Klenerman; J L Chen; Y Koezuka; I A Roberts; D A Price; G Dusheiko; C Milstein; A Fersht; L Luzzatto; V Cerundolo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

9.  Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C.

Authors:  Simona Urbani; Carolina Boni; Gabriele Missale; Gianfranco Elia; Cristina Cavallo; Marco Massari; Giovanni Raimondo; Carlo Ferrari
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

10.  A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients.

Authors:  H-G Liu; Z-P Fan; W-W Chen; H-Y Yang; Q-F Liu; H Zhang; P Tien; F-S Wang
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.